Navigation Links
Wyeth Embroiled in a Lawsuit over its Hormone Replacement Therapy

Monday saw the conclusion of the first of a wave of prescription drug trials with the hearing of the closing arguments as Wyeth defended// its hormone replacement therapy Prempro against claims of increased risk of heart disease, stroke and cancer.

Zoe Littlepage, an attorney for plaintiff Linda Reeves, told the jury at the federal court in Little Rock said, "Wyeth was negligent in not testing the drug and not knowing the truth about their drug."

However Wyeth's lawyer Jane Bockus told the panel of nine women and three men that the company had been warning doctors as early as 1991 of a reported increase in malignancies among patients taking its hormone replacement therapy and that the therapy should not be prescribed for over a year without a follow-up exam.

On Reeves testimony it was revealed that she took Prempro for more than eight years.

Bockus said, "Clearly the label contained adequate information," to allow doctors to decide on patient treatment.

This is the first trial of 5,000 lawsuits filed against Wyeth for Prempro.

Reeves, 67, and her lawyer told the jury at the U.S. Court for the Eastern District of Arkansas that consuming Prempro caused the growth of a breast tumor, for which she had to undergo a mastectomy.

Prempro is a combination of the hormones estrogen and progesterone to overcome the effects of menopause and has been sold in the United States since 1995.

Wyeth’s lawyers argued that the drug company had met its ethical and legal obligations in determining the treatment's safety, before U.S. District Judge William R. Wilson, Jr.

Reeves’ lawyers have said that she is seeking an unspecified judgment that could exceed $1 million.


NL
'"/>




Page: 1

Related medicine news :

1. Wyeth Launches Vaccine for Pneumococcal Disease in India
2. Wyeth Pharma Wins Law Suit
3. Verdict Against Wyeth Pharma in Prempro Case
4. Simmering Curry - Murg Masala Embroiled In a Thick Soup
5. Medical Education in Australia Embroiled in Scandals
6. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
7. Lawsuit Against Sunscreen Makers For False Claims of Protection Against Skin Cancer
8. Lawsuit against Google
9. KFC Targeted in Lawsuit
10. American Wins Lawsuit Over Penile Implant Malfunction
11. Soft Drink Companies Settle Lawsuit
Post Your Comments:
(Date:5/23/2012)... second edition of Law and the American Health Care ... 2012. Building on its 1997 predecessor, the second edition ... intersection of law and the U.S. health care system. ... a time of unprecedented change in how health care ... of study, the book focuses on how a dramatically ...
(Date:5/23/2012)... of the same kind, thereby triggering skeletal and cardiac ... from the RUB Heart and Diabetes Center NRW in ... an interdisciplinary research project with colleagues from the universities ... Journal of Biological Chemistry . , One ... stabilizing filaments inside of the cells. Different mutations in ...
(Date:5/23/2012)... FRANCISCO The number of viral infections during infancy ... to a new study from researchers in the Netherlands. ... later in childhood, this association was due in part ... in infancy, particularly rhinovirus, are thought to be a ... unclear whether this association is due to the viruses ...
(Date:5/23/2012)... present findings on prostate cancer risk, screening, treatment ... of the American Urological Association May 19-23 in ... to provide expert comment for reporters covering the ... presented and their embargo dates include: , ... surgery hormone therapy , Embargoed until 10:30 a.m. ...
(Date:5/22/2012)... MAYWOOD, Ill. -- Children born with cleft lip, ... medical challenges beyond appearance. , Patients can face ... well as social and psychological challenges, Laura Swibel ... colleagues write in the June 2012 issue of ... "The management of patients with craniofacial syndromes is ...
Breaking Medicine News(10 mins):Health News:Landmark textbook on health care and the US legal system released 2Health News:Aggregating instead of stabilizing: New insights into the mechanisms of heart disease 2Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4Health News:Cleft lip/palate cause much more than cosmetic problems 2
... leading provider of Electronic Medical Record and practice billing solutions for ... joined the company as Chief Commercial Officer. Flormann brings 25 ... support and business and market development to Glenwood Systems. , ... ...
... OH, December 11, 2008 -- More than half a million ... and preterm births are on the rise. Late preterm ... (approximately 4 to 6 weeks before the mother,s due date), ... the large number of affected babies, many people are unaware ...
... ACEL ) today reported its financial results for the first ... The company recorded a net loss of approximately $2.8 million, or ... ended Oct. 31., compared to a net loss of $2.7 million, ... quarter of fiscal 2008. Research and development expenses increased by ...
... PALO ALTO, Calif., Dec. 10 Varian Medical Systems (NYSE: ... first quarter of fiscal year 2009 following the close of regular ... be followed by a teleconference available to all interested parties at ... Varian Medical Systems quarterly results can be accessed on January 29, ...
... Global Med Technologies(R), Inc.,("Global Med" or the ... information technology company, today announced that due to,inquiries ... letter that was,received from Victory Park Capital Advisors, ... to Global Med,s Board of Directors to investigate ...
... Some are genetically driven to eat more calories, study ... people may be genetically driven to seek out more ... Dec. 11 issue of the New England Journal ... a particular gene variant tend to eat more energy-dense ...
Other Medicine News:Health News:Glenwood Systems, LLC Appoints Ron Flormann Chief Commercial Officer 2Health News:Late preterm births present serious risks to newborns 2Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 3Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 4Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 5Health News:Varian Medical Systems Schedules First Quarter FY2009 News Release and Conference Call 2Health News:Varian Medical Systems Schedules First Quarter FY2009 News Release and Conference Call 3Health News:Global Med Technologies(R), Inc. Clarifies Proposal Received from Victory Park Capital Advisors, LLC 2Health News:Gene May Make Kids Crave Junk Food 2Health News:Gene May Make Kids Crave Junk Food 3
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... FREMONT, Calif., Oct. 29 Vermillion, Inc.,(OTC Bulletin ... with Quest,Diagnostics to extend the Strategic Alliance Agreement ... enable the companies to continue,work on the development ... The OVA1 test is intended to identify women ...
... consistent differences in bone mineral density at the,lumbar ... (fluticasone,propionate and salmeterol inhalation powder) and salmeterol, ... of Advair(R) in patients,with COPD, PHILADELPHIA, Oct. ... from a three-year study of patients with,Chronic Obstructive ...
Other Medicine Technology:Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 2Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 3Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 4Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD 2Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD 3
Swing-Arm™ Scatter Shield® provides lower extremity protection for personnel close to the tube. 24"Wx32"L lead shield swings 180 along table. Ideal for cardiac cath, special studies, electr...
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre...
... Primarily designed to prevent lower body exposure ... used on any table where X-ray fluoroscopy is ... protection in applications where C-arm fluoroscopy units are ... are offered, each equipped with a 17 cm ...
Economy Apron, Excellent Protection, Value Priced...
Medicine Products: